Pancreatic Cancer Action Network
Kristina Harris has extensive work experience in the field of translational research, biomarker discovery, and clinical development. Kristina is currently working as the Senior Director of Translational Research for Precision Promise at the Pancreatic Cancer Action Network. Prior to this, they worked as the Director of Translational Medicine - Early Discovery Lead at Rubius Therapeutics, where they were responsible for mechanistic assessments of Red Cell Therapeutics in cancer and autoimmune diseases. Kristina has also held positions at the Immune Tolerance Network as the Director of Biomarker & Discovery Research and Associate Director of Biomarker & Discovery Research. Before that, they worked at the University of Maryland School of Medicine as an Assistant Professor and Research Associate. Kristina began their career as a Graduate Research Assistant at the University of Maryland, Baltimore, where they pursued a Ph.D. in Molecular Medicine.
Kristina Harris has attended the University of Maryland School of Medicine. No specific years, degree, or field of study information is provided.
This person is not in any offices
Pancreatic Cancer Action Network
1 followers
The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to dramatically improve patient outcomes.